UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 307

Sortiert nach

European Charcot Foundation Symposium “Treatment Strategies in Multiple Sclerosis. From pathophysiology to clinical practice”. 17–19 November 2005: Results from a Round Table Discussion on Rules for individual patient care in MS. J. Palace (chair), M. Amato, G. Comi, G. Edan, M. Friedrichs Bosmans, O.R. Hommes

Journal of the neurological sciences, 2007-08, Vol.259 (1), p.133-134

2007

Link zum Volltext

Verfügbarkeit prüfen

Natalizumab and drug holiday in clinical practice: An observational study in very active relapsing remitting Multiple Sclerosis patients

Journal of the neurological sciences, 2011-09, Vol.308 (1), p.98-102

2011

Link zum Volltext

Verfügbarkeit prüfen

Assessment of cognitive dysfunction in multiple sclerosis

Journal of the neurological sciences, 2006-06, Vol.245 (1), p.169-175

2006

Link zum Volltext

Verfügbarkeit prüfen

A new treatment era in multiple sclerosis: Clinical applications of new concepts

Journal of the neurological sciences, 2011-07, Vol.306 (1), p.170-172

2011

Link zum Volltext

Verfügbarkeit prüfen

Rationale for the use of mitoxantrone in multiple sclerosis

Journal of the neurological sciences, 2004-08, Vol.223 (1), p.35-39

2004

Link zum Volltext

Verfügbarkeit prüfen

Long-term experience with induction treatment regimens in multiple sclerosis

Journal of the neurological sciences, 2009-02, Vol.277, p.S46-S49

2009

Link zum Volltext

Verfügbarkeit prüfen

Benefit 11: Long-term follow-up study of patients with clinically isolated syndrome treated with interferon beta-1b

Journal of the neurological sciences, 2013-10, Vol.333, p.e383-e383

2013

Link zum Volltext

Verfügbarkeit prüfen

The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: Rationale, objectives and state of advancement

Journal of the neurological sciences, 2009-11, Vol.286 (1), p.114-118

2009

Link zum Volltext

Verfügbarkeit prüfen

A real-world analysis of factors associated with high healthcare resource utilization and costs in patients with myasthenia gravis receiving second-line treatment

Journal of the neurological sciences, 2023-02, Vol.445, p.120531-120531, Article 120531

2023

Link zum Volltext

Verfügbarkeit prüfen

Current therapeutic recommendations in multiple sclerosis

Journal of the neurological sciences, 2009-12, Vol.287, p.S37-S45

Berger, Thomas

2009

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppression: Promises and failures

Journal of the neurological sciences, 2007-08, Vol.259 (1), p.74-78

Oger, Joël

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stage

Journal of the neurological sciences, 2022-01, Vol.432, p.120074-120074, Article 120074

2022

Link zum Volltext

Verfügbarkeit prüfen

Predictive markers of disease evolution after a CIS in everyday practice

Journal of the neurological sciences, 2014-08, Vol.343 (1), p.8-14

2014

Link zum Volltext

Verfügbarkeit prüfen

Early treatment in multiple sclerosis

Journal of the neurological sciences, 2011-12, Vol.311, p.S24-S28

Elovaara, Irina

2011

Link zum Volltext

Verfügbarkeit prüfen

Glatiramer acetate treatment in PPMS: Why males appear to respond favorably

Journal of the neurological sciences, 2009-11, Vol.286 (1), p.92-98

2009

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppression followed by immunomodulation

Journal of the neurological sciences, 2009-02, Vol.277, p.S50-S54

Boggild, Mike

2009

Link zum Volltext

Verfügbarkeit prüfen

Cognitive and psychiatric comorbidities in neuromyelitis optica

Journal of the neurological sciences, 2016-01, Vol.360, p.4-9

2016

Link zum Volltext

Verfügbarkeit prüfen

Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: An open-label comparative study of efficacy and safety

Journal of the neurological sciences, 2008-03, Vol.266 (1), p.25-30

2008

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the retinal nerve fiber layer in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis

Journal of the neurological sciences, 2017-12, Vol.383, p.108-113

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Journal of the neurological sciences, 2018-08, Vol.391, p.72-76

2018

Link zum Volltext

Verfügbarkeit prüfen

Mitoxantrone in progressive multiple sclerosis: when and how to treat?

Journal of the neurological sciences, 2003-02, Vol.206 (2), p.203-208

Gonsette, R.E

2003

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis

Journal of the neurological sciences, 2017-09, Vol.380, p.256-261

2017

Link zum Volltext

Verfügbarkeit prüfen

Concepts of induction and escalation therapy in multiple sclerosis

Journal of the neurological sciences, 2009-02, Vol.277, p.S42-S45

Rieckmann, Peter

2009

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts

Journal of the neurological sciences, 2010-05, Vol.292 (1), p.57-62

2010

Link zum Volltext

Verfügbarkeit prüfen

Fatigue in multiple sclerosis — A brief review

Journal of the neurological sciences, 2012-12, Vol.323 (1), p.9-15

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 307

Suche als RSS-Feed

Aktive Filter

SpracheArabisch

SpracheCroatian

SprachePolnisch

PublikationsformBuchkapitel

Zeitschrift / SerieJournal Of The Neurological Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(307)
Mit Volltextzugriff
(307)

Publikationsform

Artikel
(307)

Sprache

Englisch
(307)
Japanisch
(35)

Erscheinungsjahr

n.n

Thema

Humans
(294)
Clinical Neurology
(293)
Life Sciences & Biomedicine
(293)
Neurosciences
(293)
Neurosciences & Neurology
(293)
Science & Technology
(293)
Neurology
(274)
Multiple Sclerosis
(270)
Female
(231)
Male
(225)
Adult
(214)
Middle Aged
(177)
Biological And Medical Sciences
(164)
Medical Sciences
(164)
Young Adult
(72)
Magnetic Resonance Imaging
(63)
Multiple Sclerosis - Physiopathology
(61)
Disability Evaluation
(58)
Multiple Sclerosis - Complications
(57)
Adolescent
(54)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(307)
Ingenta
(307)
Elsevier ScienceDirect Journals Complete
(307)
MEDLINE
(294)
IngentaConnect Journals
(87)

Zeitschrift / Serie

J Neurol Sci
(1)

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Natalizumab and drug holiday in clinical practice: An observational study in very active relapsing remitting Multiple Sclerosis patients

Assessment of cognitive dysfunction in multiple sclerosis

A new treatment era in multiple sclerosis: Clinical applications of new concepts

Rationale for the use of mitoxantrone in multiple sclerosis

Long-term experience with induction treatment regimens in multiple sclerosis

Benefit 11: Long-term follow-up study of patients with clinically isolated syndrome treated with interferon beta-1b

The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: Rationale, objectives and state of advancement

A real-world analysis of factors associated with high healthcare resource utilization and costs in patients with myasthenia gravis receiving second-line treatment

Current therapeutic recommendations in multiple sclerosis

Immunosuppression: Promises and failures

Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stage

Predictive markers of disease evolution after a CIS in everyday practice

Early treatment in multiple sclerosis

Glatiramer acetate treatment in PPMS: Why males appear to respond favorably

Immunosuppression followed by immunomodulation

Cognitive and psychiatric comorbidities in neuromyelitis optica

Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: An open-label comparative study of efficacy and safety

Evaluation of the retinal nerve fiber layer in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Mitoxantrone in progressive multiple sclerosis: when and how to treat?

Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis

Concepts of induction and escalation therapy in multiple sclerosis

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts

Fatigue in multiple sclerosis — A brief review

Aktive Filter

Suchergebnisse filtern